Clinical Trial Update: Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure [NA]

View source ↗

Summary

Clinical pharmacology trial completed to determine the dose of OPC-61815 injection equivalent to tolvaptan 15 mg tablet in patients with congestive heart failur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• OPC-61815
• tolvaptan (tolvaptan)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Congestive Heart Failure | NA | Status: COMPLETED | Results posted: 2021-07-28